David Yang Email & Phone Number

Taipei, TW

台灣 臺北市

(Commercial Excellence, Data & Digital, BD&L)- DESIGN go-to-market model with performance matrix to evolve promotion and solution-based operation in entire field transformation journey.- PIONEER use case series (channel sequencing & segmented messages) to identify capability level, customer needs and value of engagement and shape differentiated OCE.

Taiwan

- LEAD BEST sequential strategic portfolio strategy (KISQALI, PIQRAY, AFINITOR) as curated packages for different patient segments in HR+MBC treatment journey.- DEVELOP internal and external alliance (TESTING platforms with QIAGEN and ACT Genomics) to create launch excellence (PIQRAY).- COLLABROATE with brand team to achieve goal of KISQALI post-menopausal.

Taipei City, Taiwan

- TRANSFORM new dedicated commercial model (4 FTEs) for VOTRIENT within 6 months to meet P&L optimization goal and enterprise priority as restructure BC commercial team independency.- OPTIMIZE life cycle management by aligning key customers values with potential NOVARTIS business development (ex. PSMA-Radioligand therapy in prostate cancer, PIK3CA.

Taipei City, Taiwan

• STRATEGIZE counter plan (VOTRIENT RCC ) to expand the 1st line market with best TKI-TKI-IO treatment scenario.- ACCELERATE selected key Center of Excellence (VOTRIENT STS) to maximize business potential as.
• Achieved VOTRIENT YTD sales target 105% and 18.0% growth versus actual 17’.
• Maximize brand and corporate SOV through successfully launching public awareness video and enhance key stakeholder… Show more - STRATEGIZE counter plan (VOTRIENT RCC ) to expand the 1st line market with best TKI-TKI-IO.
• Maximize brand and corporate SOV through successfully launching public awareness video and enhance key stakeholder engagement to strengthen brand loyalty.
• 2018 10th EGM best practice winner by vote of the regional panel Show less

Taipei City, Taiwan

• STRATEGIZE counter plan (VOTRIENT RCC ) to expand the 1st line market with best TKI-TKI-IO treatment scenario.- ACCELERATE selected key Center of Excellence (VOTRIENT STS) to maximize business potential as.
• Achieved VOTRIENT YTD sales target 105% and 44.0% growth versus actual 16’.
• Significantly Increased RCC patient share from 15% to 25% by maximizing window of reimbursement… Show more - STRATEGIZE counter plan (VOTRIENT RCC ) to expand the 1st line market with best TKI-TKI-IO treatment.
• Significantly Increased RCC patient share from 15% to 25% by maximizing window of reimbursement relaxation.
• Increase brand SOV by disseminating the updated real world evidence through video clips and livestream in several commercial events.
• Successfully Launched RCC global standalone virtue meeting for 28 physicians and participant rate over 70%. Show less

Taipei City, Taiwan

• Products: VOTRIENT(Soft tissue sarcoma), TYKERB (Breast cancer), ZOMETA (Breast cancer/Prostate cancer) - STRATEGIZE counter plan (VOTRIENT RCC ) to expand the 1st line market with best TKI-TKI-IO treatment scenario..

Taipei City, Taiwan

- DRIVE key brand (ZOMETA) growth momentum through sharpening competitive brand essentials- UNLEASH windows of reimbursement opportunity (AFINITOR BC) through driving robust pre-approval case to support customer needs and priority.- STREGTHEN differentiated messages (VOTRIENT RCC) to overcome market restrictions (TKI-mTOR vs. TKI-TKI)

Taipei City, Taiwan

• Responsibilities
• Territory: Mackay Memorial Hospital(All branches, except Taitung), Cathay General Hospital(all branches), NTUH Hsin-Chu Branch
• Products: AFINITOR (Breast cancer/Renal cell carcinoma), VOTRIENT(Renal cell carcinoma/Soft tissue sarcoma), TYKERB (Breast cancer), FEMARA (Breast cancer), ZOMETA (Breast cancer/prostate cancer), VOTUBIA (Tuberous.

Taiwan

- IDENTIFY market trends to build a sales pipeline for medium/long term in accordance with targets.- CREATE roadmap for generics pipeline (Oncology and Psychology) through integrating product development matrix in R&D, manufacturing, patent, sourcing, and sales operation.

Taiwan

- OVERSEE patient’s condition to ensure all issues (drug-related problems) are being treated appropriately within critical care teamwork.- MASTER proficiency in preceptor roles and actively emulates education/mentorship skills.